The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients
The Effect of a 2-month Somatic Serious Games on the Cognition of Schizophrenia Patients
1 other identifier
interventional
84
1 country
1
Brief Summary
Schizophrenia is a common and severe mental disorder that imposes a significant burden on patients. Cognitive impairment can be regarded as one of the core symptoms of schizophrenia, which is prevalent among patients with schizophrenia. In recent years, digital rehabilitation therapy based on games has shown a remarkable development trend among schizophrenia patients. Serious games, or application games, refer to those games aimed not only for entertainment. They can educate, train, or change the behavior of players through interesting intervention forms and have been applied in many healthcare fields. This study aims to develop a somatosensory interactive game for patients with cognitive impairment of schizophrenia to improve their cognitive functions and verify its effectiveness and feasibility through a randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 19, 2026
CompletedFirst Submitted
Initial submission to the registry
April 22, 2026
CompletedFirst Posted
Study publicly available on registry
April 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
April 29, 2026
April 1, 2026
2.2 years
April 22, 2026
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MCCB
Using MATRIC Consensus Cognitive Battery (MCCB) to measure the cognition.
Baseline, immediately post-intervention , 1-month follow-up, 3-month follow-up, 6-month follow-up, 12-month follow-up, and 24-month follow-up
Secondary Outcomes (5)
BPRS
Baseline, immediately post-intervention , 1-month follow-up, 3-month follow-up, 6-month follow-up, 12-month follow-up, and 24-month follow-up
WHOQOL-BREF
Baseline, immediately post-intervention , 1-month follow-up, 3-month follow-up, 6-month follow-up, 12-month follow-up, and 24-month follow-up
MMAS-8
Baseline, immediately post-intervention , 1-month follow-up, 3-month follow-up, 6-month follow-up, 12-month follow-up, and 24-month follow-up
SDSS
Baseline, immediately post-intervention , 1-month follow-up, 3-month follow-up, 6-month follow-up, 12-month follow-up, and 24-month follow-up
uMARS
immediately post-intervention
Study Arms (2)
Intervention group
EXPERIMENTALThe group member (n = 42) will receive approximately 30 minutes of digital rehabilitation training at least three times a week for 8 weeks, with professional supervision and guidance as they use the games. Cognitive function and quality of life were assessed at baseline and follow-up.
Controlled group
NO INTERVENTIONParticipants in this arm (n = 42) will receive routine inpatient psychiatric rehabilitation and care during the same period.
Interventions
A serious game for 5 cognitive functions, including 10 games, uses somatosensory technology to achieve interaction, and provides cognitive training close to life scenes for patients with schizophrenia.
Eligibility Criteria
You may qualify if:
- Registered in the Shanghai Mental Health Information Management System and hospitalized in the designated district-level mental health center wards;
- Schizophrenia patients meeting the diagnostic criteria of schizophrenia in the International Classification of Diseases (ICD-10);
- years old;
- Good self-care ability;
- Clinically stable (without acute exacerbation) for at least 1 week before enrollment, with a stable dose of antipsychotic drugs or other concomitant psychotropic drugs for at least 1 week;
- No hand disabilities, and can use mobile phones or tablets normally;
- Have a primary school education or above;
- Normal vision and hearing, or within the normal range after correction;
- Own and be able to independently use a smart phone or other electronic devices;
- Patients and their families have given informed consent to this study, and voluntarily cooperate to participate in the intervention and sign the informed consent form.
You may not qualify if:
- not reside in Shanghai after discharge;
- suffering from serious physical or brain organic diseases;
- comorbid with other psychotic disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Mental Health Center
Shanghai, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Cai
Shanghai Mental Health Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2026
First Posted
April 29, 2026
Study Start
April 19, 2026
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share